Back to top
more

U.S. Physical Therapy (USPH)

(Real Time Quote from BATS)

$72.41 USD

72.41
61,837

+0.39 (0.54%)

Updated Aug 6, 2025 03:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks News

Zacks Equity Research

Analysts Estimate U.S. Physical Therapy (USPH) to Report a Decline in Earnings: What to Look Out for

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

DGX vs. USPH: Which Stock Should Value Investors Buy Now?

DGX vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

U.S. Physical Therapy (USPH) Q1 Earnings and Revenues Surpass Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 50.00% and 9.95%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: U.S. Physical Therapy (USPH) Q1 Earnings Expected to Decline

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Analysts Estimate U.S. Physical Therapy (USPH) to Report a Decline in Earnings: What to Look Out for

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

U.S. Physical Therapy (USPH) Q4 Earnings Lag Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of -5.88% and 0.74%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

EHC or USPH: Which Is the Better Value Stock Right Now?

EHC vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

U.S. Physical Therapy (USPH) Q3 Earnings Match Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 0.00% and -3.48%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

U.S. Physical Therapy (USPH) Earnings Expected to Grow: Should You Buy?

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

AMED vs. USPH: Which Stock Is the Better Value Option?

AMED vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

U.S. Physical Therapy (USPH) Q2 Earnings Meet Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 0.00% and 1.17%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

U.S. Physical Therapy (USPH) Reports Next Week: Wall Street Expects Earnings Growth

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

EHC or USPH: Which Is the Better Value Stock Right Now?

EHC vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Zacks.com featured highlights include: Cadence Design System, LPL Financial, CSX and U.S. Physical Therapy

Zacks.com featured highlights include: Cadence Design System, LPL Financial, CSX and U.S. Physical Therapy

Zacks Equity Research

4 GARP Stocks to Scoop Up for Maximum Returns

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

Zacks Equity Research

What Makes U.S. Physical Therapy (USPH) a Strong Momentum Stock: Buy Now?

Does U.S. Physical Therapy (USPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

U.S. Physical Therapy (USPH) Tops Q1 Earnings and Revenue Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 6.45% and 0.46%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

U.S. Physical Therapy (USPH) Earnings Expected to Grow: Should You Buy?

U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

ADUS or USPH: Which Is the Better Value Stock Right Now?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for April 25th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 25th

Zacks Equity Research

ADUS vs. USPH: Which Stock Is the Better Value Option?

ADUS vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

ARA vs. USPH: Which Stock Should Value Investors Buy Now?

ARA vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

ARA vs. USPH: Which Stock Should Value Investors Buy Now?

ARA vs. USPH: Which Stock Is the Better Value Option?